Rapid, Accurate COVID-19 Diagnostic & Antibody Tests
With over 6 million – and increasing every day – confirmed cases of COVID-19 in just the United States, an abundance of rapid, highly accurate diagnostic tests is the only way to identify, control, and track this virus. GENETWORx has built a laboratory capable of conducting hundreds of thousands of tests every day to serve our US customers. GENETWORx provides both the nasopharyngeal and saliva COVID-19 tests to support ongoing, frequent, and sequential testing and screening, as well as antibody tests to let patients know if they’ve developed an immune response to the COVID-19 virus.
Below is information on each test offered by GENETWORx to help you determine which test is better suited for your needs.
The GENETWORx COVID-19 Nasopharyngeal Test
The GENETWORx nasopharyngeal test is the gold standard when it comes to diagnosing COVID-19. Due to its 99% specificity and sensitivity, the GENETWORx test picks up the virus earlier than other laboratory tests, resulting in 99% accurate results and a significantly reduced risk of false negatives.
The FDA has acknowledged that the GENETWORx nasopharyngeal test meets the conditions outlined in the FDA Guidelines for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency for the allowable modifications to the CDC EUA, on March 26, 2020.
A healthcare provider or practice must administer GENETWORx’s nasopharyngeal test. Clients of GENETWORX receive their testing kits within 72 hours. The diagnostic test kit will include the nasopharyngeal swab and the universal transport media in a vial to ensure RNA and DNA survival.
Once the test is administered, the vial and test order are to be put in the provided bag and the prepaid FedEx package, which will be delivered right to a GENETWORx lab. GENETWORx has one of the fastest results-reporting platforms in the world, making results available in less than 72 hours. These results can be accessed by the patient or the provider in the online portal, as well as via text or phone, or our COVID-19 software solution, named Aura.
Aura users have expedited turnaround times of COVID-19 test results, as this end-to-end digital management system significantly reduces laboratory process time. Aura ensures a compliant, safe, healthy population for healthcare providers, schools, universities, governments, cities, employers, and more. Learn more about the benefits of this software.
The GENETWORx COVID-19 Saliva Test
GENETWORx’s saliva tests yield an accuracy greater than 98%, as well as the convenience of self-administration – though a prescription is still required. In order to avoid a testing rejection, those taking the test should not eat, drink, smoke, or chew gum 30 minutes before giving the saliva sample.
The GENETWORX saliva test includes a saliva-collecting funnel with stabilizing liquid. The person taking the test will spit into the funnel until the amount of liquid saliva (not bubbles) reaches the fill-to line. Once the amount has been reached, the individual will hold the tube upright and close the funnel lid until there’s a loud click. The click is the liquid in the lid being released into the tube and mixed into the saliva. Next, the individual will hold the tube upright and unscrew the funnel from the tube, using the small cap to close the tube tightly. After shaking the capped tube for 5 seconds, the specimen is put into the biohazard bag, then into a shipping box and the FedEx return pack.
Due to one of the fastest results-reporting platforms in the world, results can be accessed in GENETWORx’s portal in less than 72 hours, as well as on the phone or by text.
Aura users will receive a notification when their test results are available. This end-to-end management software ensures a safe, compliant, healthy population for healthcare providers, schools, universities, governments, cities, employers, and more. Learn more about the benefits of this software.
COVID-19 Total Antibody (IgM & IgG) Tests
The GENETWORx COVID-19 Total Antibody (IgM & IgG) assay is a blood test that is performed to determine if someone has had an immune response to COVID-19.
The COVID-19 Antibody Test has a 99.8% specificity and 100% sensitivity and only checks to see if the immune system has responded to the infection.
If there are antibodies present in the blood, this is a sign that the individual has likely already had COVID-19. The COVID-19 Antibody Test is not for diagnosing an active COVID-19 infection; it is only for testing whether the immune system, the body’s defense against illness, has responded to the infection.
The presence of antibodies to SARS-CoV-2 indicates that the patient being tested, whether symptomatic or asymptomatic, has had an immune response to the virus. Total antibody tests detect both IgG and IgM in the blood to provide a clearer disease-state picture. These assays are more sensitive than the use of IgG or IgM alone for early detection of an immune response.
While the test is most accurate when performed at least 14 days after infection, if you don’t have symptoms but suspect you may have been infected, this test can be conducted at any point.
With one of the fastest results-reporting platforms in the world, results can be accessed in GENETWORx’s portal in less than 72 hours, as well as on the phone or by text.
Ready for a test?
For more information on our testing capabilities or for instructions on the gathering of samples,
please contact GENETWORx by:
This form is for ordering new test kits for healthcare providers, employers, governments, etc.
It is not for receiving your test results.
We look forward to receiving your inquiry. Please allow up to 24 hours for response. Thank you!